Holen Sie sich die Stockscreener-App
4.58
3.58%
-0.17
Handel nachbörslich:
8.05
3.47
+75.76%
Schlusskurs vom Vortag:
$4.75
Offen:
$4.72
24-Stunden-Volumen:
59,092
Relative Volume:
0.15
Marktkapitalisierung:
$2.29M
Einnahmen:
$29.78M
Nettoeinkommen (Verlust:
$-39.94M
KGV:
-0.074
EPS:
-61.9139
Netto-Cashflow:
$-16.12M
1W Leistung:
-25.16%
1M Leistung:
+638.83%
6M Leistung:
-26.01%
1J Leistung:
-96.10%
1-Tages-Spanne:
$4.24
$4.72
1-Wochen-Bereich:
$4.24
$6.9772
52-Wochen-Spanne:
$0.432
$123.35
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Vergleichen Sie XXII mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
4.58 | 2.10M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
22nd Century Group stock soars after expanding VLN cigarette partnerships By Investing.com - Investing.com Nigeria
22nd Century Group stock soars after expanding VLN cigarette partnerships - Investing.com
Tobacco brands partner with 22nd Century to expand reduced nicotine cigarettes - Investing.com UK
22nd Century Group Partners with Tobacco Brands to Promote VLN Reduced Nicotine Cigarettes in Compliance with FDA Standards - Quiver Quantitative
Exclusive: Major Tobacco Brands Adopt 95% Reduced-Nicotine Cigarettes Ahead of FDA Mandate - Stock Titan
What makes 22nd Century Group Inc. stock price move sharplySwing Trade Signals - beatles.ru
22nd Century Group stockholders approve share increase and reverse split measures - Investing.com India
22nd Century Approves Key Proposals at Annual Meeting - TipRanks
22nd Century Advances FDA Renewal for VLN - Tobacco Reporter
Top Premarket Decliners - MarketScreener
The Nicotine Reset: 22nd Century Group's Path to Dominance in a Post-Addiction World - AInvest
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less - The Globe and Mail
Top 3 Risk Off Stocks That May Rocket Higher In Q3S&W Seed (NASDAQ:SANW), Shineco (NASDAQ:SISI) - Benzinga
22nd Century Targets Q4 to Have 100mm VLN to FDA - Tobacco Reporter
22nd Century Group developing 100mm very low nicotine cigarette - MSN
22nd Century Group to develop 100mm reduced nicotine cigarettes By Investing.com - Investing.com Canada
22nd Century Group to develop 100mm reduced nicotine cigarettes - Investing.com
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption - TradingView
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain - Morningstar
22nd Century Launches Reduced Nicotine Cigarettes Across 1,700 Major Retail Stores | XXII Stock News - Stock Titan
22nd Century (XXII) Plans to Sell 8.59 Million Shares of Common Stock | XXII Stock News - GuruFocus
XXII files S-3 to register 8.6 M cashless-exercise shares; no cash proceeds | XXII SEC FilingForm S-3 - Stock Titan
Trading Halt Imposed on 22nd Century (XXII) Pending News Announcement | XXII Stock News - GuruFocus
22nd Century Group Announces Reverse Stock Split - Investing.com
22nd Century Announces Reverse Stock Split Plan - TipRanks
22nd Century Group IncAuthorizes 1-For-23 Reverse Stock Split - TradingView
22nd Century Group Announces Reverse Stock Split By Investing.com - Investing.com Canada
22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board - marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Sees Significant Drop in Short Interest - Defense World
22nd Century limits fiscal 2024 executive compensation, proposes another reverse stock split - Winston-Salem Journal
22nd Century Group (NASDAQ:XXII) Given Sell (E+) Rating at Weiss Ratings - Defense World
22nd Century Group (NASDAQ:XXII) Cut to “Sell” at Wall Street Zen - Defense World
22nd Century Modifies Securities Purchase Agreement - TipRanks
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group - The Globe and Mail
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 | XXII Stock News - GuruFocus
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 - The Manila Times
22nd Century Group, Inc. CEO Larry Firestone to Present Corporate Update at Emerging Growth Conference on May 21, 2025 - Nasdaq
22Nd Century Revenue Growth From Continued Expansion Of Cmo Volume - marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call Transcript - Insider Monkey
22nd Century Sees 50% Jump from Q4 2024 to Q1 2025 - Tobacco Reporter
22nd Century: Q1 Earnings Snapshot - CT Insider
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Restructuring - GuruFocus
22nd Century Group reports Q1 2025 earnings By Investing.com - Investing.com Nigeria
Earnings call transcript: 22nd Century Group Reports Q1 2025 Revenue Surge - Investing.com Australia
22nd Century Group Reports First Quarter 2025 Financial Results - GuruFocus
22ND CENTURY GROUP Earnings Results: $XXII Reports Quarterly Earnings - Nasdaq
22nd Century Group reports Q1 2025 earnings - Investing.com
22nd Century Group Reports 50% Sequential Sales Increase in First Quarter 2025, Advances Growth Strategy and New Product Launches - Nasdaq
22nd Century Group, Inc. (XXII): Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Deadline March 22, 2019 - ACCESS Newswire
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.40%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):